Anti-calreticulin segregates anti-Ro sera in systemic lupus erythematosus: Anti-calreticulin is present in sera with anti-Ro alone but not in anti-Ro sera with anti-La or anti-ribonucleoprotein

Journal of Rheumatology

Volumn 27, Issue 1, 2000, Pages 128-134

  Scofield, R Hal ^a,b,c,d,g   Racila, Doina M ^f   Gordon, Tom P ^e   Kurien, Biji T ^a   Sontheimer, Richard D ^g  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c BSEB 306   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e FLINDERS MEDICAL CENTRE   (Australia)

^f UNIVERSITY OF IOWA   (United States)

^g NONE

Author keywords

Autoantibodies; Autoantigens; Calreticulin; Ribonucleoproteins; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; CALCIUM BINDING PROTEIN; CALRETICULIN; RIBONUCLEOPROTEIN; RIBONUCLEOPROTEIN ANTIBODY;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIGENS; CALCIUM-BINDING PROTEINS; CALRETICULIN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RIBONUCLEOPROTEINS; RNA, SMALL CYTOPLASMIC; TRANSCRIPTION FACTORS;

EID: 0033958566     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Clark G, Reichlin M, Tomasi TB Jr. Characterization of a soluble cyloplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969;102:117-22.
2. Harley JB, Scofield RH. Systemic lupus erythematosus: RNA protein autoantigens, models of disease heterogeneity, and theories of etiology. J Clin Immunol 1991;11:297-307.
3. Harley JB, Sestak AS, Willis LG, Fu SM, Hansen JA, Reichlin M. A model for disease heterogeneity in systemic lupus erythematosus: relationships between histocompatibility antigens, autoantibodies and lymphopenia or renal disease. Arthritis Rheum 1989;32:826-36.
4. Harley JB, Alexander EL, Bias WB, et al. Anti-Ro/SSA and anti-La/SSB in patients with Sjögren's syndrome. Arthritis Rheum 1986;29:196-206.
5. Harley JB, Reichlin M, Arnett FC, Alexander EL. Bias WB. Provost TT. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science 1986; 232:1145-7.
6. Scofield RH, Frank MB, Neas BR, et al. Cooperative association of T cell receptor β receptor alleles in the production of anti-Ro in systemic lupus erythematosus. Clin Immunol Immunopathol 1994;72:335-41.
7. Reveille JD, MacLeod MJ, Whittington K, Arnett FC. Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro(SS-A)/La(SS-B) autoantibody responses. J Immunol 1993;146:3871-6.
8. Scofield RH, Harley JB. Association of anti-Ro/SSA autoantibodies with glutamine in position 34 of DQAI and leucine in position 26 of DQB1. Arthritis Rheum 1994;37:961-2.
9. Itoh Y, Reichlin M. Autoantibodies to the Ro/SSA antigen are conformation dependent. I: anti-60 kD antibodies are mainly directed to the native protein; anti-52 kD antibodies are mainly directed to the denatured protein. Autoimmunity 1992;14:57-65.
10. O'Brien CA, Margelot K. Wolin SL. Xenopus Ro rihonucleoproteins: members of an evolutionarily conserved class of cyloplasmic ribonucleoproteins. Proc Natl Acad Sci USA 1993;90:7250-4.
11. Farris AD, Gross JK, Hanas JS, Harley JB. Genes for Y1 and Y3 Ro RNAs have class 3 RNA polymerase III promoter structure and are unlinked on mouse chromosome 6. Gene 1996;174:35-42.
12. Stefano JE. Purified lupus antigen La recognizes an oligo uridylate stretch common to the 3′ termini of RNA polymerase III transcripts. Cell 1984;36:145-54.
13. Yoo CL, Wolin SL. The yeast La protein is required for the 3′ endonucleolytic cleavage that matures tRNA precursors. Cell 1997;89:393-402.
14. Huhn P. Pruijn GJ, van Venrooij WJ, Bachmann M. Characteriztion of the autoantigen La(SS-B) as a dsRNA unwinding enzyme. Nucl Acids Res 1997;5:410-6.
15. Slobe RL, Pluk W, van Venrooij WJ, Pruijn GJ. Ro ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein-protein interactions. J Mol Biol 1992;227:361-6.
16. Boire G, Gendron M, Monast N. Bastin B. Ménard HA. Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunologic evidence that the 52-kD protein is not a Ro protein. Clin Exp Immunol 1995;100:489-98.
17. Ben-Chetrit E, Chan EK, Sullivan KF. Tan EM. A 52-Kd protein is a novel component of the SSA/Ro antigenic particle. J Exp Med 1988;167:1560-71.
18. Pruijn GJM, Slobbe RL, van Venrooij WJ. Analysis of protein-RNA interactions within the ribonucleoprotein complexes. Nucl Acids Res 1991;19:5173-80.
19. Peek R, Pruijn GL, van der Kamp AJ, van Venrooij WJ. Subcellular distribution of Ro ribonucleoprotein complexes and their constituents. J Cell Sci 1993;106:929-35.
20. Kelekar A, Saitta MR, Keene JD. Molecular composition of Ro small ribonucleoprotein complexes in human cells, Intracellular localization of the 60- and 52-kD proteins. J Clin Invest 1994;93:1637-44.
21. O'Brien CA. Wolin SL. A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5S RNA precursors. Gene Develop 1994;8:2891-903.
22. Somheimer RD, Nguyen TQ, Cheng S-T, Lieu S-T, Capra JD. The unveiling of calreticulin - A clinically relevant tour of modern molecular biology. J Invest Med 1995;43:362-70.
23. Michalak M, Milner RE, Burns K, Opas M. Calreticulin. Biochem J 1992;285:681-92.
24. Nauseef WM, McCormick SJ, Clark RA. Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J Biol Chem 1995;270:4741-7.
25. Guan SH, Falick AM, Williams DE, Cashman JR. Evidence for complex formation between rabbit lung flavin-containing monooxygenase and calreticulin. Biochemistry 1991;30:9892-900.
26. Egglelon P, Lieu TS, Zappi EG, et al. Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein. Clin Immunol Immunopathol 1994;72:405-9.
27. Kishore U, Sontheimer RD, Sastry KN, et al. The systemic lupus erythematosus disease autoantigen - calreticulin can inhibit C1q association with immune complexes. Clin Exp Immunol 1997;108:181-90.
28. Dedhar S. Rennie PS, Shago M, et al. Inhibition of nuclear hormone receptor activity by calreticulin. Nature 1994;367:480-3.
29. Burns K, Duggan B, Atkinson EA, et al. Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature 1994;367:476-80.
30. Atreya CD, Singh NK, Nakhasi HL. The rubella virus RNA binding activity of human calreticulin is localized to the N-terminal domain. J Virol 1995;69:3848-51.
31. Singhi NK, Atreya CD, Nakhasi HL. Identification of calreticulin as a rubella virus RNA binding protein. Proc Natl Acad Sci USA 1994;91:12770-4.
32. Cheng S-T, Nguyen TQ, Yang YS. Capra JD. Sontheimer RD. Calreticulin binds hYRNA and the 52-kDA polypeptide component of the Ro/SSA ribonucleoprotein. J Immunol 1996;156:4484-91.
33. Lieu TS, Sontheimer RD. A subpopulation of WIL-2 cell calreticulin molecules is associated with Ro/SSA ribonucleoprotein particles. Lupus 1997;6:40-7.
34. Rokeach LA, Haselby JA. Meilof JF, et al. Characterization of the autoantigen calreticulin. J Immunol 1991;147:3031-9.
35. Lieu TS, Newkirk MM, Capra JD, Sontheimer RD. Molecular characterization of human Ro/SS-A antigen. Amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity of a corresponding synthetic peptide. J Clin Invest 1988;82:96-101.
36. Lux FA, McCauliffe DP, Büttner DW, et al. Serological cross-reactivity between a human Ro/SS-A autoantigen (calreticulin) and the γRAL-1 antigen of Onchocerca volvulus. J Clin Invest 1992;89:1945-51.
37. McCauliffe DP, Lux FA, Lieu T-S, et al. Molecular cloning, expression, and chromosome 19 localization of a human Ro/SS-A autoantigen. J Clin Invest 1990;85:1379-91.
38. Boehm J. Orth T, van Nguyen P, Soling H-D. Systemic lupus erythematosus is associated with increased autoantibody tilers against calreticulin and Grp94. but calreticulin is not the Ro/SS-A antigen. Eur J Clin Invest 1994;24:248-57.
39. Routsias JG, Tzioufas AG, Sakarellos-Daitsiotis M, Sakarellos C, Moutspoulos HM. Calreticulin synthetic peptide analogues: antipeptide antibodies in autoimmune rheumatic diseases. Clin Exp Immunol 1993;91:437-41.
40. Lu J. Willis AC, Sim RB. A calreticulin-like protein co-purifies with a '60 kD' component of Ro/SSA, but is not recognized by antibodies in Sjögren's syndrome sera. Clin Exp Immunol 1993;94:429-34.
41. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
42. Frank MB, McArthur R, Harley JB, Fujisaku A. Anti-Ro (SSA) autoantibodies are associated with T Cell receptor beta genes in systemic lupus erythematosus patients. J Clin Invest 1990;85:33-9.
43. Kujisaku A, Frank MB, Neas B, Reichlin M, Harley JB. HLA-DQ gene complement and other histocompatibility relationships in man with the anti-Ro/SSA autoantibody response in systemic lupus erythematosus. J Clin Invest 1989;86:606-11.
44. Scofield RH, Zhang K-C, Kurien BT, Harley JB. Anti-Ro fine specificity defined by multiple antigenic peptides identifies components of tertiary epitopes. Clin Exp Immunol 1997; 109:480-7.
45. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Arthritis Rheum 1993;36:340-7.
46. Beer RG, Rischmueller M, Coates T, et al. Nonprecipitating anti-La(SS-B) autoantibodies in primary Sjögren's syndrome. Clin Immunol Immunopathol 1996;79:314-8.
47. Ouchterlony O. Antigen-antibody reaction in gels. Acta Pathol Microbiol Scand 1949;26:507-15.
48. Yamagata H, Harley JB, Reichlin M. Molecular properties of the Ro/SSA antigen and ELISA for quantitation of antibody. J Clin Invest 1984;74:625-33.
49. Racila DM, Sontheimer RD. C1q inhibits autoantibody binding to calreticulin lupus. Lupus 1999;8:300-4.
50. Buyon JP, Slade SG, Chan EKL, Tan EM, Winchester R. Effective separation of the 52 kDa SSA/Ro polypeptide from the 48 kDa SSB/La polypeptide by altering conditions of polyacrylamide gel electrophoresis. J Immunol Methods 1990;129:207-10.
51. Itoh Y, Rader MD, Reichlin M. Heterogeneity of the Ro/SSA antigen and autoantibody-Ro/SSA response: evidence of four antigenically distinct forms. Clin Exp Immunol 1990;81:45-51.
52. Scofield RH, Henry WE, Kurien BT, James JA, Harley JB. Immunization with short peptides from the sequence of the systemic lupus erythematosus associated 60 kD Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity. J Immunol 1996;156:4059-66.
53. Scofield RH, Harley JB. Autoantigenicity of Ro/SSA antigen is related to a nucleocapsid protein of vesicular stomatitis virus. Proc Natl Acad Sci USA 1991;88:3343-7.
54. Huang SC, Yu H, Scofield RH, Harley JB. Human anti-Ro autoantibodies bind peptides accessible to the surface of the native Ro autoantigen. Scand J Immunol 1995;41:220-8.
55. Solheim JC, Harris MR, Kindle CS, Hansen TH. Prominence of beta-2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J Immunol 1997;158:2236-41.
56. Tector M, Zhang Q, Salter RD. Beta 2-microglobulin and calnexin can independently promote folding and disulfide bond formation in class I histocompatibility proteins. Mol Immunol 1997;34:401-8.
57. Duncan RC, Nakhasi HL. La autoantigen binding to a 5′ cis element of rubella virus RNA correlates with element function in vivo. Gene 1997;201:137-49.
58. Topfer F, Gordon T, McCluskey J. Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La(SSB) and Ro(SSA). Proc Natl Acad Sci USA 1995;92:875-9.
59. Keech CL, Gordon TP, McCluskey J. The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity. J Immunol 1996;157:3694-9.
60. Tseng CE, Chan EK, Miranda E, Gross M, Di Donato F, Buyon JP. The 52-kd protein as a target of intermolecular spreading of the immune response to components of the SSA/Ro-SSB/La complex. Arthritis Rheum 1997;40:936-44.
61. Kinoshita G, Keech CL, Sontheimer RD, Purcell A, McCluskey J, Gordon TP. Spreading of the immune response from 52 KD Ro and 60 kD Ro to calreticulin in experimental autoimmunity. Lupus 1998;7:7-11.
62. Scofield RH, Kurien BT, Kaufman KM, Barber U, James JA, Harley JB. Immunization of mice with human 60 kD Ro peptides results in epitope spreading if the peptides are highly homologous between man and mouse. Arthritis Rheum 1999;42:1017-24.
63. James JA, Gross T, Scofield RH, Harley JB. Immunoglobulin spreading and autoimmune disease after peptide immunization: Sm B/B′n-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity. J Exp Med 1995;181:453-6.
64. Craft J, Fattenejads S. Self antigens and epitope spreading in systemic autoimmunity. Arthritis Rheum 1997;40:1374-82.
65. Lin RH, Mamula MJ, Hardin JA, Janeway CA Jr. Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med 1993;173:1433-9.
66. Mamula MJ, Lin RH, Janeway CA Jr, Hardin JA. Breaking tolerance with foreign and self co-immunogens. A study of B and T cell epitopes of cytochrome c. J Immunol 1992;149:789-95.
67. Mamula MJ. The inability to process a self-peptide allows autoreactive T cells to escape tolerance. J Exp Med 1993; 177:567-71.
68. Deshmukh US, Lewis JE, Gaskin F, et al. Immune response to Ro60 and its peptides in mice. 1. The nature of the immunogen and endogenous autoantigen determine the specificities of the induced autoantihodies. J Exp Med 1999;189:531-40.